Eribulin extends overall survival for patients with advanced liposarcoma and leiomyosarcoma

Extensive lymph node surgery may not be necessary for some patients with melanoma

First effective adjuvant chemotherapy for high-risk, localised prostate cancer

Novel JAK inhibitor pacritinib proves effective for easing symptoms of myelofibrosis

New ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocytic leukaemia

Obinutuzumab doubles remission duration in patients with relapsed, indolent non-hodgkin lymphoma

First-in-class targeted drug daratumumab shows promise in heavily treatment-resistant multiple myeloma

Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse prediction

Pembrolizumab for head and neck cancer

Pembrolizumab shows promising activity against head and neck cancer

Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial

Genomic marker predicts anti-PD-1 response in several cancers